In a report released today, Chris Cooper from Goldman Sachs reiterated a Sell rating on Nanosonics Limited (NNCSF – Research Report). The company’s shares closed last Thursday at $3.09.
According to TipRanks, Cooper is a 2-star analyst with an average return of 0.6% and a 58.62% success rate. Cooper covers the Healthcare sector, focusing on stocks such as CSL, Pro Medicus Limited, and Cochlear Limited.
The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Nanosonics Limited with a $3.07 average price target.
See Insiders’ Hot Stocks on TipRanks >>
NNCSF market cap is currently $916.9M and has a P/E ratio of 133.26.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Nanosonics Ltd is an Australia based healthcare equipment manufacturing company. It manufactures and distributes the trophon EPR ultrasound probe disinfector, which reduces the risk of ultrasound-related cross-infection. It also manufactures the associated consumables and accessories such as the trophon wall mount, trophon printer, trophon cart, trophon curved probe positioner and others. In addition, the company manufactures and commercializes infection control and decontamination products and services and related technologies. The entity operates in Australia and other countries, of which key revenue is derived from North America.
Read More on NNCSF:
